CHF 0.84
(-6.44%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | - CHF | -100.0% |
2022 | 15.05 Million CHF | 38.92% |
2021 | 10.83 Million CHF | 20.13% |
2020 | 9.02 Million CHF | 47.21% |
2019 | 6.12 Million CHF | 93.0% |
2018 | 3.17 Million CHF | -0.17% |
2017 | 3.18 Million CHF | -29.97% |
2016 | 4.54 Million CHF | -10.97% |
2015 | 5.1 Million CHF | -34.42% |
2014 | 7.77 Million CHF | 4.52% |
2013 | 7.44 Million CHF | -13.26% |
2012 | 8.58 Million CHF | 109.15% |
2011 | 4.1 Million CHF | -0.37% |
2010 | 4.11 Million CHF | -56.57% |
2009 | 9.48 Million CHF | 0.0% |
2008 | - CHF | -100.0% |
2007 | 5.44 Million CHF | -0.54% |
2006 | 5.47 Million CHF | 0.0% |
2005 | - CHF | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q2 | - CHF | 0.0% |
2023 FY | - CHF | -100.0% |
2023 Q4 | - CHF | 0.0% |
2023 Q2 | 16.75 Million CHF | 0.0% |
2022 Q4 | 15.05 Million CHF | 0.0% |
2022 Q2 | 12.34 Million CHF | 0.0% |
2022 FY | 15.05 Million CHF | 38.92% |
2021 Q4 | 10.83 Million CHF | 0.0% |
2021 Q2 | 14.35 Million CHF | 0.0% |
2021 FY | 10.83 Million CHF | 20.13% |
2020 FY | 9.02 Million CHF | 47.21% |
2020 Q2 | 5.66 Million CHF | 0.0% |
2020 Q4 | 9.02 Million CHF | 0.0% |
2019 Q2 | 6.64 Million CHF | 0.0% |
2019 FY | 6.12 Million CHF | 93.0% |
2019 Q4 | 6.12 Million CHF | 0.0% |
2018 Q2 | 3.54 Million CHF | 0.0% |
2018 Q4 | 3.17 Million CHF | 0.0% |
2018 FY | 3.17 Million CHF | -0.17% |
2017 FY | 3.18 Million CHF | -29.97% |
2017 Q4 | 3.18 Million CHF | 0.0% |
2017 Q2 | 4.26 Million CHF | 0.0% |
2016 Q4 | 4.54 Million CHF | 0.0% |
2016 Q2 | 4.85 Million CHF | 0.0% |
2016 FY | 4.54 Million CHF | -10.97% |
2015 Q4 | 5.1 Million CHF | 0.0% |
2015 FY | 5.1 Million CHF | -34.42% |
2015 Q2 | 8.65 Million CHF | 0.0% |
2014 FY | 7.77 Million CHF | 4.52% |
2014 Q2 | 7.21 Million CHF | 0.0% |
2014 Q4 | 7.77 Million CHF | 0.0% |
2013 Q4 | 7.44 Million CHF | 0.0% |
2013 Q2 | 8.42 Million CHF | 0.0% |
2013 FY | 7.44 Million CHF | -13.26% |
2012 Q2 | 8.71 Million CHF | 0.0% |
2012 Q4 | 8.58 Million CHF | 0.0% |
2012 FY | 8.58 Million CHF | 109.15% |
2011 Q4 | 4.1 Million CHF | 0.0% |
2011 FY | 4.1 Million CHF | -0.37% |
2011 Q2 | 9.12 Million CHF | 0.0% |
2010 Q2 | 8.97 Million CHF | 0.0% |
2010 FY | 4.11 Million CHF | -56.57% |
2010 Q4 | 4.11 Million CHF | 0.0% |
2009 Q4 | 9.48 Million CHF | 0.0% |
2009 FY | 9.48 Million CHF | 0.0% |
2008 FY | - CHF | -100.0% |
2007 FY | 5.44 Million CHF | -0.54% |
2006 FY | 5.47 Million CHF | 0.0% |
2005 FY | - CHF | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Addex Therapeutics Ltd | 344.33 Thousand CHF | 100.0% |
BB Biotech AG | 304.9 Million CHF | 100.0% |
Basilea Pharmaceutica AG | 128.6 Million CHF | 100.0% |
Idorsia Ltd | 1.2 Billion CHF | 100.0% |
Kuros Biosciences AG | 5.51 Million CHF | 100.0% |
Molecular Partners AG | 3.65 Million CHF | 100.0% |
Relief Therapeutics Holding AG | 4.31 Million CHF | 100.0% |
Santhera Pharmaceuticals Holding AG | 25.06 Million CHF | 100.0% |